SENSEX
NIFTY
GOLD
USD/INR

Weather

image 31    C

Economy News

The Economic Times

Economy / The Economic Times

details

FDA approval puts Wockhardts Zaynich in $9 billion antibiotics market

Wockhardts newly approved antibiotic Zaynich has the potential to transform the treatment of drug-resistant infections, according to Mahesh Patel, the scientist behind the drug. Approved by the US FDA for complicated urinary tract infections, Zaynich combines cefepime and zidebactam, using a novel beta-lactam enhancer mechanism that blocks two key steps in bacterial cell-wall synthesis, helping it overcome virtually all known resistance mechanisms.

1 Jun 2026 5:01 am